nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—ACSL3—renal system—cervical cancer	0.0359	0.0485	CbGeAlD
Icosapent—PPARG—Irinotecan—Topotecan—cervical cancer	0.0344	1	CbGdCrCtD
Icosapent—SLC8A1—renal system—cervical cancer	0.0298	0.0402	CbGeAlD
Icosapent—ACSL3—female reproductive system—cervical cancer	0.0288	0.0388	CbGeAlD
Icosapent—ACSL3—female gonad—cervical cancer	0.0262	0.0353	CbGeAlD
Icosapent—SLC8A1—female reproductive system—cervical cancer	0.0238	0.0322	CbGeAlD
Icosapent—TRPV1—epithelium—cervical cancer	0.0214	0.0289	CbGeAlD
Icosapent—FADS1—uterine cervix—cervical cancer	0.0212	0.0287	CbGeAlD
Icosapent—FADS1—decidua—cervical cancer	0.0202	0.0273	CbGeAlD
Icosapent—TRPV1—renal system—cervical cancer	0.0199	0.0268	CbGeAlD
Icosapent—ACSL4—uterine cervix—cervical cancer	0.0193	0.026	CbGeAlD
Icosapent—FADS1—endometrium—cervical cancer	0.0192	0.0259	CbGeAlD
Icosapent—FADS1—mammalian vulva—cervical cancer	0.0186	0.0251	CbGeAlD
Icosapent—PPARD—uterine cervix—cervical cancer	0.0185	0.025	CbGeAlD
Icosapent—ACSL4—decidua—cervical cancer	0.0184	0.0248	CbGeAlD
Icosapent—ACSL4—renal system—cervical cancer	0.018	0.0244	CbGeAlD
Icosapent—FADS1—uterus—cervical cancer	0.0177	0.0239	CbGeAlD
Icosapent—PPARD—decidua—cervical cancer	0.0176	0.0238	CbGeAlD
Icosapent—FABP7—female reproductive system—cervical cancer	0.0175	0.0237	CbGeAlD
Icosapent—ACSL4—endometrium—cervical cancer	0.0174	0.0235	CbGeAlD
Icosapent—ACSL4—mammalian vulva—cervical cancer	0.0169	0.0228	CbGeAlD
Icosapent—PPARD—mammalian vulva—cervical cancer	0.0162	0.0219	CbGeAlD
Icosapent—ACSL4—uterus—cervical cancer	0.0161	0.0217	CbGeAlD
Icosapent—TRPV1—female reproductive system—cervical cancer	0.0159	0.0215	CbGeAlD
Icosapent—FADS1—female gonad—cervical cancer	0.0145	0.0195	CbGeAlD
Icosapent—ACSL4—female reproductive system—cervical cancer	0.0144	0.0195	CbGeAlD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0144	0.0641	CbGpPWpGaD
Icosapent—FADS1—vagina—cervical cancer	0.0144	0.0194	CbGeAlD
Icosapent—PPARD—female reproductive system—cervical cancer	0.0139	0.0187	CbGeAlD
Icosapent—ACSL4—female gonad—cervical cancer	0.0131	0.0177	CbGeAlD
Icosapent—ACSL4—vagina—cervical cancer	0.0131	0.0176	CbGeAlD
Icosapent—PPARD—female gonad—cervical cancer	0.0126	0.017	CbGeAlD
Icosapent—PPARD—vagina—cervical cancer	0.0125	0.0169	CbGeAlD
Icosapent—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0116	0.0517	CbGpPWpGaD
Icosapent—PPARD—Nuclear Receptors—RARB—cervical cancer	0.0106	0.0473	CbGpPWpGaD
Icosapent—FADS1—lymph node—cervical cancer	0.00931	0.0126	CbGeAlD
Icosapent—FFAR1—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—cervical cancer	0.00897	0.0399	CbGpPWpGaD
Icosapent—PPARG—epithelium—cervical cancer	0.00875	0.0118	CbGeAlD
Icosapent—ACSL4—lymph node—cervical cancer	0.00845	0.0114	CbGeAlD
Icosapent—PPARD—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.0084	0.0374	CbGpPWpGaD
Icosapent—PPARG—decidua—cervical cancer	0.00827	0.0112	CbGeAlD
Icosapent—PPARG—renal system—cervical cancer	0.00812	0.011	CbGeAlD
Icosapent—PPARD—lymph node—cervical cancer	0.00811	0.011	CbGeAlD
Icosapent—FFAR1—Incretin synthesis, secretion, and inactivation—CTNNB1—cervical cancer	0.00798	0.0355	CbGpPWpGaD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00786	0.035	CbGpPWpGaD
Icosapent—PPARG—mammalian vulva—cervical cancer	0.00759	0.0102	CbGeAlD
Icosapent—PPARG—uterus—cervical cancer	0.00723	0.00976	CbGeAlD
Icosapent—PPARG—female reproductive system—cervical cancer	0.0065	0.00877	CbGeAlD
Icosapent—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00634	0.0282	CbGpPWpGaD
Icosapent—PPARG—Noncanonical Wnt signaling pathway—WNT5A—cervical cancer	0.00629	0.028	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—WNT2—cervical cancer	0.00601	0.0267	CbGpPWpGaD
Icosapent—PPARG—female gonad—cervical cancer	0.00591	0.00798	CbGeAlD
Icosapent—PPARG—vagina—cervical cancer	0.00588	0.00794	CbGeAlD
Icosapent—PPARG—Nuclear Receptors—RARB—cervical cancer	0.0058	0.0258	CbGpPWpGaD
Icosapent—PPARG—SREBP signalling—YY1—cervical cancer	0.00575	0.0256	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—YY1—cervical cancer	0.00568	0.0253	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00558	0.0248	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—SERPIND1—cervical cancer	0.0053	0.0236	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—GP6—cervical cancer	0.0053	0.0236	CbGpPWpGaD
Icosapent—PTGS1—epithelium—cervical cancer	0.00468	0.00631	CbGeAlD
Icosapent—PTGS1—uterine cervix—cervical cancer	0.00464	0.00626	CbGeAlD
Icosapent—SLC8A1—Hemostasis—GP5—cervical cancer	0.00463	0.0206	CbGpPWpGaD
Icosapent—PPARG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00459	0.0204	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—WNT5A—cervical cancer	0.00455	0.0203	CbGpPWpGaD
Icosapent—PTGS2—epithelium—cervical cancer	0.00447	0.00604	CbGeAlD
Icosapent—PTGS2—uterine cervix—cervical cancer	0.00443	0.00598	CbGeAlD
Icosapent—PTGS1—renal system—cervical cancer	0.00434	0.00586	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—TAAR6—cervical cancer	0.00425	0.0189	CbGpPWpGaD
Icosapent—PTGS1—endometrium—cervical cancer	0.00419	0.00566	CbGeAlD
Icosapent—PTGS2—renal system—cervical cancer	0.00415	0.0056	CbGeAlD
Icosapent—PTGS1—mammalian vulva—cervical cancer	0.00406	0.00548	CbGeAlD
Icosapent—PTGS2—endometrium—cervical cancer	0.00401	0.00541	CbGeAlD
Icosapent—PTGS1—uterus—cervical cancer	0.00387	0.00522	CbGeAlD
Icosapent—PPARG—lymph node—cervical cancer	0.0038	0.00513	CbGeAlD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—NOTCH1—cervical cancer	0.00374	0.0166	CbGpPWpGaD
Icosapent—PTGS2—uterus—cervical cancer	0.00369	0.00499	CbGeAlD
Icosapent—PTGS1—female reproductive system—cervical cancer	0.00347	0.00469	CbGeAlD
Icosapent—PTGS2—female reproductive system—cervical cancer	0.00332	0.00448	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—WNT2—cervical cancer	0.00332	0.0148	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—PIAS3—cervical cancer	0.00326	0.0145	CbGpPWpGaD
Icosapent—PTGS1—female gonad—cervical cancer	0.00316	0.00427	CbGeAlD
Icosapent—PTGS1—vagina—cervical cancer	0.00314	0.00424	CbGeAlD
Icosapent—PTGS2—female gonad—cervical cancer	0.00302	0.00408	CbGeAlD
Icosapent—PTGS2—vagina—cervical cancer	0.003	0.00405	CbGeAlD
Icosapent—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.00279	0.0124	CbGpPWpGaD
Icosapent—FFAR1—Peptide hormone metabolism—CTNNB1—cervical cancer	0.00271	0.012	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—WNT5A—cervical cancer	0.00252	0.0112	CbGpPWpGaD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—cervical cancer	0.00249	0.0111	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—TAAR6—cervical cancer	0.0024	0.0107	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—INSM1—cervical cancer	0.0022	0.0098	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—TAAR6—cervical cancer	0.00218	0.00971	CbGpPWpGaD
Icosapent—PTGS1—lymph node—cervical cancer	0.00203	0.00274	CbGeAlD
Icosapent—PTGS2—lymph node—cervical cancer	0.00194	0.00262	CbGeAlD
Icosapent—PPARG—Circadian rythm related genes—UBE3A—cervical cancer	0.00188	0.00836	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—WNT2—cervical cancer	0.0017	0.00758	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—AKAP13—cervical cancer	0.00165	0.00733	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CA9—cervical cancer	0.0015	0.00667	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKAP13—cervical cancer	0.0015	0.00665	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—RARB—cervical cancer	0.00145	0.00645	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—MTOR—cervical cancer	0.00139	0.00617	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.00132	0.00586	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—cervical cancer	0.00131	0.00585	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—WNT5A—cervical cancer	0.00129	0.00574	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TAAR6—cervical cancer	0.00129	0.00574	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CA9—cervical cancer	0.00126	0.00559	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—cervical cancer	0.00123	0.00547	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CA9—cervical cancer	0.00114	0.00506	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CA9—cervical cancer	0.00114	0.00506	CbGpPWpGaD
Icosapent—PPARG—SREBP signalling—MTOR—cervical cancer	0.00111	0.00492	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—CTNNB1—cervical cancer	0.00108	0.00482	CbGpPWpGaD
Icosapent—PPARD—Ectoderm Differentiation—CTNNB1—cervical cancer	0.00103	0.00459	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00102	0.00454	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—WNT2—cervical cancer	0.00101	0.00448	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000991	0.00441	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000961	0.00428	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—STAT3—cervical cancer	0.000944	0.0042	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HES1—cervical cancer	0.000929	0.00413	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000887	0.00395	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKAP13—cervical cancer	0.000884	0.00393	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—cervical cancer	0.000874	0.00389	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.000845	0.00376	CbGpPWpGaD
Icosapent—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.000794	0.00353	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—RARB—cervical cancer	0.000792	0.00352	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000787	0.0035	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—WNT5A—cervical cancer	0.000763	0.00339	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.000732	0.00326	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—RARB—cervical cancer	0.000699	0.00311	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CA9—cervical cancer	0.000639	0.00284	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000625	0.00278	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—MTHFR—cervical cancer	0.000609	0.00271	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000598	0.00266	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000595	0.00265	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—CTNNB1—cervical cancer	0.000591	0.00263	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NOTCH2—cervical cancer	0.000535	0.00238	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000525	0.00233	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.000525	0.00233	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—STAT3—cervical cancer	0.000515	0.00229	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CTNNB1—cervical cancer	0.000511	0.00227	CbGpPWpGaD
Icosapent—FADS1—Metabolism—MTHFR—cervical cancer	0.00051	0.00227	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—NOTCH2—cervical cancer	0.000463	0.00206	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—MTHFR—cervical cancer	0.000461	0.00205	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—MTHFR—cervical cancer	0.000461	0.00205	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HES1—cervical cancer	0.000439	0.00195	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HES1—cervical cancer	0.000405	0.0018	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—cervical cancer	0.000399	0.00177	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TERT—cervical cancer	0.000385	0.00171	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—RARB—cervical cancer	0.000381	0.0017	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	0.000368	0.00164	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FGFR3—cervical cancer	0.000353	0.00157	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CA9—cervical cancer	0.000349	0.00155	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NOTCH1—cervical cancer	0.000331	0.00147	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000331	0.00147	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000325	0.00145	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NOTCH1—cervical cancer	0.000306	0.00136	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—EGFR—cervical cancer	0.000295	0.00131	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—NOTCH1—cervical cancer	0.000286	0.00127	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	0.000281	0.00125	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—cervical cancer	0.000277	0.00123	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MTHFR—cervical cancer	0.000259	0.00115	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NOTCH2—cervical cancer	0.000253	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000251	0.00111	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MTOR—cervical cancer	0.000248	0.0011	CbGpPWpGaD
Icosapent—PTGS2—Disease—WNT2—cervical cancer	0.000245	0.00109	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CA9—cervical cancer	0.000244	0.00109	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000242	0.00107	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—cervical cancer	0.000236	0.00105	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CASP3—cervical cancer	0.000228	0.00102	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CTNNB1—cervical cancer	0.00022	0.000979	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CTNNB1—cervical cancer	0.000203	0.000904	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CA9—cervical cancer	0.000194	0.000863	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STAT3—cervical cancer	0.000192	0.000854	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000191	0.000851	CbGpPWpGaD
Icosapent—PTGS2—Disease—WNT5A—cervical cancer	0.000186	0.000827	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—STAT3—cervical cancer	0.000177	0.000788	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—cervical cancer	0.000174	0.000776	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—cervical cancer	0.000161	0.000716	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000161	0.000715	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NOTCH1—cervical cancer	0.000156	0.000696	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—cervical cancer	0.000146	0.000651	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—cervical cancer	0.000142	0.00063	CbGpPWpGaD
Icosapent—PTGS2—Disease—HES1—cervical cancer	0.000107	0.000476	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—cervical cancer	9.92e-05	0.000441	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—cervical cancer	9.4e-05	0.000418	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—cervical cancer	9.37e-05	0.000417	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR3—cervical cancer	8.6e-05	0.000383	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOTCH1—cervical cancer	8.08e-05	0.000359	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—cervical cancer	7.87e-05	0.00035	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTOR—cervical cancer	6.05e-05	0.000269	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—cervical cancer	6.04e-05	0.000269	CbGpPWpGaD
Icosapent—PTGS2—Disease—CTNNB1—cervical cancer	5.37e-05	0.000239	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT3—cervical cancer	4.68e-05	0.000208	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—cervical cancer	4.25e-05	0.000189	CbGpPWpGaD
